Literature DB >> 9811674

Modulation of immune system function by measles virus infection: role of soluble factor and direct infection.

R S Fujinami1, X Sun, J M Howell, J C Jenkin, J B Burns.   

Abstract

Measles virus infection can result in a variety of immunologic defects. We have begun studies to determine the basis for the lack of immune responsiveness to antigen and mitogen following infection. Here we present data showing that Epstein-Barr virus-transformed B-cell lines infected with measles virus produce a soluble factor that can inhibit antigen-specific T-cell proliferation and inhibit the proliferation of uninfected B cells. The soluble factor was neither interleukin-10, transforming growth factor beta, nor alpha/beta interferon. B cells infected with measles virus or treated with the soluble factor were unable to present antigen to T cells in a manner that supported antigen-specific proliferation. This could represent one mechanism of how measles virus limits T-cell expansion. However, we found that once CD4(+) or CD8(+) T cells were activated, their cytolytic activity was intact whether infected with measles virus or treated with soluble factor. Thus, while slow to be generated these cytoxic cells could participate in viral clearance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9811674      PMCID: PMC110427     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Effect of measles vaccine on immunologic responsiveness.

Authors:  P Fireman; G Friday; J Kumate
Journal:  Pediatrics       Date:  1969-02       Impact factor: 7.124

2.  Abnormalities in lymphocyte proliferation in classical and atypical measles infection.

Authors:  A Finkel; P B Dent
Journal:  Cell Immunol       Date:  1973-01       Impact factor: 4.868

3.  In vitro effects of measles virus on proliferating human lymphocytes.

Authors:  B Zweiman
Journal:  J Immunol       Date:  1971-05       Impact factor: 5.422

4.  Cell-mediated immunity during natural measles infection.

Authors:  H C Whittle; J Dossetor; A Oduloju; A D Bryceson; B M Greenwood
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

5.  Alterations in expression of measles virus polypeptides by antibody: molecular events in antibody-induced antigenic modulation.

Authors:  R S Fujinami; M B Oldstone
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

6.  Studies on the mechanism of measles virus-induced suppression of lymphocyte functions in vitro: lack of a role for interferon and monocytes.

Authors:  C J Lucas; J Ubels-Postma; J M Galama; A Rezee
Journal:  Cell Immunol       Date:  1978-05       Impact factor: 4.868

7.  Interaction of measles virus glycoproteins with the surface of uninfected peripheral blood lymphocytes induces immunosuppression in vitro.

Authors:  J Schlender; J J Schnorr; P Spielhoffer; T Cathomen; R Cattaneo; M A Billeter; V ter Meulen; S Schneider-Schaulies
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

8.  Immune reactive measles virus polypeptides on the cell's surface: turnover and relationship of the glycoproteins to each other and to HLA determinants.

Authors:  R S Fujinami; J G Sissons; M B Oldstone
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

9.  Isolation of myelin basic protein-reactive T-cell lines from normal human blood.

Authors:  J Burns; A Rosenzweig; B Zweiman; R P Lisak
Journal:  Cell Immunol       Date:  1983-10-15       Impact factor: 4.868

10.  Failure to cleave measles virus fusion protein in lymphoid cells.

Authors:  R S Fujinami; M B Oldstone
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

View more
  12 in total

Review 1.  Immune containment and consequences of measles virus infection in healthy and immunocompromised individuals.

Authors:  Sallie R Permar; Diane E Griffin; Norman L Letvin
Journal:  Clin Vaccine Immunol       Date:  2006-04

2.  Proteolytic cleavage of the fusion protein but not membrane fusion is required for measles virus-induced immunosuppression in vitro.

Authors:  A Weidmann; A Maisner; W Garten; M Seufert; V ter Meulen; S Schneider-Schaulies
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Measles virus-induced immunosuppression in vitro is independent of complex glycosylation of viral glycoproteins and of hemifusion.

Authors:  A Weidmann; C Fischer; S Ohgimoto; C Rüth; V ter Meulen; S Schneider-Schaulies
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

4.  Selective in vivo suppression of T lymphocyte responses in experimental measles virus infection.

Authors:  S Niewiesk; M Götzelmann; V ter Meulen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

5.  Does Zika virus infection induce prolonged remissions in children with idiopathic nephrotic syndrome?

Authors:  Carolina Peralta-Aros; Víctor García-Nieto
Journal:  Pediatr Nephrol       Date:  2017-02-07       Impact factor: 3.714

Review 6.  Measles virus interactions with cellular receptors: consequences for viral pathogenesis.

Authors:  J Schneider-Schaulies; V ter Meulen; S Schneider-Schaulies
Journal:  J Neurovirol       Date:  2001-10       Impact factor: 2.643

7.  Edmonston measles virus prevents increased cell surface expression of peptide-loaded major histocompatibility complex class II proteins in human peripheral monocytes.

Authors:  Mamadi Yilla; Carole Hickman; Marcia McGrew; Elizabeth Meade; William J Bellini
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

8.  Cell surface delivery of the measles virus nucleoprotein: a viral strategy to induce immunosuppression.

Authors:  Julien C Marie; Frédéric Saltel; Jean-Michel Escola; Pierre Jurdic; T Fabian Wild; Branka Horvat
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

9.  Cytokine imbalance after measles virus infection has no correlation with immune suppression.

Authors:  Mary Carsillo; Kay Klapproth; Stefan Niewiesk
Journal:  J Virol       Date:  2009-05-06       Impact factor: 5.103

Review 10.  Idiopathic nephrotic syndrome: the EBV hypothesis.

Authors:  Claire Dossier; Agnès Jamin; Georges Deschênes
Journal:  Pediatr Res       Date:  2016-09-28       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.